Search results
Results from the WOW.Com Content Network
An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics (drugs used to relieve pain). Equianalgesic charts are used for calculation of an equivalent dose (a dose which would offer an equal amount of analgesia) between different analgesics. [1]
The fatal dose in humans is estimated to be 150–200 milligrams per kilogram, which is 10.5–14 grams for a typical 70 kg (150 lb) adult, equivalent to about 75–100 cups of coffee. [ 148 ] [ 149 ] There are cases where doses as low as 57 milligrams per kilogram have been fatal. [ 150 ]
Ergotamine/caffeine, sold under the brand name Cafergot among others, is a fixed-dose combination medication used for the treatment of migraine. It contains ergotamine, as the tartrate, an alpha adrenergic blocking agent; and caffeine, a cranial vasoconstrictor. [3] Ergotamine/caffeine is available as a generic medication.
This page provides supplementary chemical data on caffeine. Caffeine ... LD 50 (median dose) 192 mg/kg (rat, oral) [3] Safety data sheet (SDS) ICSC 0405 This ...
A combination antibiotic is one in which two ingredients are added together for additional therapeutic effect. [1] One or both ingredients may be antibiotics. [1]Antibiotic combinations are increasingly important because of antimicrobial resistance. [2]
Goody's Powder has a long history of sponsoring motor racing events and teams, especially NASCAR.The Daytona Nationwide Race was sponsored by Goody's from 1982 to 1996. . Goody's is the title sponsor of the Goody's Headache Relief Shot 500 Sprint Cup Series race at Martinsville Speedway and was the title sponsor of the Goody's Headache Powder 500 Cup race at Bristol Motor Speedway from 1996 to
TL;DR: "The 'right' dose is the dose that is both maximally tolerated and achieves individualized patient’s goals for good sugar and weight control," Dr. Shenoy says.
The combination was first introduced as the name Trigesic, as the formula of 125 mg paracetamol, 230 mg aspirin, and 30 mg caffeine, in July 1950 by Squibb, which is now Bristol Myers Squibb, but was recalled in the following year due to several reports that the drug might cause blood dyscrasia. [5]